| Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials Non-small Cell Lung Cancer Collaborative Group Bmj 311 (7010), 899-909, 1995 | 3398 | 1995 |
| Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer DJ Sargent, S Marsoni, G Monges, SN Thibodeau, R Labianca, ... Journal of clinical oncology 28 (20), 3219, 2010 | 1768 | 2010 |
| Integrating liquid biopsies into the management of cancer G Siravegna, S Marsoni, S Siena, A Bardelli Nature reviews Clinical oncology 14 (9), 531-548, 2017 | 1719 | 2017 |
| Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients G Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ... Nature medicine 21 (7), 795-801, 2015 | 1091 | 2015 |
| A molecularly annotated platform of patient-derived xenografts (“xenopatients”) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer A Bertotti, G Migliardi, F Galimi, F Sassi, D Torti, C Isella, D Corà, ... Cancer discovery 1 (6), 508-523, 2011 | 1006 | 2011 |
| Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of … A Sartore-Bianchi, L Trusolino, C Martino, K Bencardino, S Lonardi, ... The Lancet Oncology 17 (6), 738-746, 2016 | 941 | 2016 |
| DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy FA Sinicrope, NR Foster, SN Thibodeau, S Marsoni, G Monges, ... Journal of the National Cancer Institute 103 (11), 863-875, 2011 | 596 | 2011 |
| DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy FA Sinicrope, NR Foster, SN Thibodeau, S Marsoni, G Monges, ... Journal of the National Cancer Institute 103 (11), 863-875, 2011 | 596 | 2011 |
| Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial MC Garassino, O Martelli, M Broggini, G Farina, S Veronese, E Rulli, ... The lancet oncology 14 (10), 981-988, 2013 | 580 | 2013 |
| Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial P Ghezzi, S Magnanini, M Rinaldini, F Berardi, G Di Biagio, F Testare, ... Jama 271 (20), 1587-1592, 1994 | 569 | 1994 |
| Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth G Germano, S Lamba, G Rospo, L Barault, A Magrì, F Maione, M Russo, ... Nature 552 (7683), 116-120, 2017 | 555 | 2017 |
| Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth G Germano, S Lamba, G Rospo, L Barault, A Magrì, F Maione, M Russo, ... Nature 552 (7683), 116-120, 2017 | 555 | 2017 |
| Early‐onset colorectal cancer in young individuals G Mauri, A Sartore‐Bianchi, AG Russo, S Marsoni, A Bardelli, S Siena Molecular oncology 13 (2), 109-131, 2019 | 496 | 2019 |
| Etoposide (VP-16–213) Current Status of an Active Anticancer Drug PJ O'Dwyer, B Leyland-Jones, MT Alonso, S Marsoni, RE Wittes New England Journal of Medicine 312 (11), 692-700, 1985 | 469 | 1985 |
| The genomic landscape of response to EGFR blockade in colorectal cancer A Bertotti, E Papp, S Jones, V Adleff, V Anagnostou, B Lupo, M Sausen, ... Nature 526 (7572), 263-267, 2015 | 456 | 2015 |
| Efficacy of adjuvant fluorouracil and folinic acid in colon cancer R Labianca, S Marsoni, G Pancera, V Torri The Lancet 345 (8955), 939, 1995 | 386* | 1995 |
| Antibody–Fc/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non–small cell lung cancer subsequent to PD-1/PD-L1 blockade G Lo Russo, M Moro, M Sommariva, V Cancila, M Boeri, G Centonze, ... Clinical Cancer Research 25 (3), 989-999, 2019 | 385 | 2019 |
| How liquid biopsies can change clinical practice in oncology G Siravegna, B Mussolin, T Venesio, S Marsoni, J Seoane, C Dive, ... Annals of Oncology 30 (10), 1580-1590, 2019 | 296 | 2019 |
| Assessment of a HER2 scoring system for colorectal cancer: results from a validation study E Valtorta, C Martino, A Sartore-Bianchi, F Penaullt-Llorca, G Viale, ... Modern Pathology 28 (11), 1481-1491, 2015 | 281 | 2015 |
| EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer V Amodio, R Yaeger, P Arcella, C Cancelliere, S Lamba, A Lorenzato, ... Cancer discovery 10 (8), 1129-1139, 2020 | 278 | 2020 |
